Cargando…
Deregulated Fcγ receptor expression in patients with CIDP
OBJECTIVE: To evaluate the expression of activating and inhibitory Fc-gamma receptors (FcγRs) before and during clinically effective therapy with IV immunoglobulin (IVIg) in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). METHODS: Peripheral blood leukocyte subsets, including...
Autores principales: | Quast, Isaak, Cueni, Flavio, Nimmerjahn, Falk, Tackenberg, Björn, Lünemann, Jan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547878/ https://www.ncbi.nlm.nih.gov/pubmed/26380354 http://dx.doi.org/10.1212/NXI.0000000000000148 |
Ejemplares similares
-
Terminal complement activation is increased and associated with disease severity in CIDP
por: Quast, Isaak, et al.
Publicado: (2016) -
Impact of FcγR variants on the response to alemtuzumab in multiple sclerosis
por: Keller, Christian W., et al.
Publicado: (2019) -
IgG-Independent Co-aggregation of FcεRI and FcγRIIB Results in LYN- and SHIP1-Dependent Tyrosine Phosphorylation of FcγRIIB in Murine Bone Marrow-Derived Mast Cells
por: Gast, Mathias, et al.
Publicado: (2018) -
Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity
por: Peschke, Benjamin, et al.
Publicado: (2017) -
Fc-Linked IgG N-Glycosylation in FcγR Knock-Out Mice
por: Zaytseva, Olga O., et al.
Publicado: (2020)